PubRank

Marleen Boelaert

Author PubWeight™ 181.31‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 2007 7.36
2 Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis 2002 7.17
3 Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance. Clin Infect Dis 2013 4.03
4 A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ 2006 3.11
5 Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis 2009 2.56
6 Control of visceral leishmaniasis in latin america-a systematic review. PLoS Negl Trop Dis 2010 2.50
7 Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ 2010 2.30
8 Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health 2008 2.28
9 Spread of vector-borne diseases and neglect of Leishmaniasis, Europe. Emerg Infect Dis 2008 2.24
10 Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin Infect Dis 2006 2.17
11 Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 2003 2.11
12 Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use. Clin Infect Dis 2012 2.00
13 Combination therapy for visceral leishmaniasis. Lancet Infect Dis 2010 1.96
14 Integrating tuberculosis and HIV care in the primary care setting in South Africa. Trop Med Int Health 2004 1.89
15 The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo. Trop Med Int Health 2004 1.89
16 Rapid diagnostic tests for neurological infections in central Africa. Lancet Infect Dis 2013 1.82
17 Chemical and environmental vector control as a contribution to the elimination of visceral leishmaniasis on the Indian subcontinent: cluster randomized controlled trials in Bangladesh, India and Nepal. BMC Med 2009 1.79
18 Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru. Clin Infect Dis 2008 1.73
19 Incidence of symptomatic and asymptomatic Leishmania donovani infections in high-endemic foci in India and Nepal: a prospective study. PLoS Negl Trop Dis 2011 1.67
20 Diagnostic accuracy of two rK39 antigen-based dipsticks and the formol gel test for rapid diagnosis of visceral leishmaniasis in northeastern Uganda. J Clin Microbiol 2005 1.67
21 Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Negl Trop Dis 2011 1.64
22 Vector control by insecticide-treated nets in the fight against visceral leishmaniasis in the Indian subcontinent, what is the evidence? Trop Med Int Health 2008 1.63
23 Effect of village-wide use of long-lasting insecticidal nets on visceral Leishmaniasis vectors in India and Nepal: a cluster randomized trial. PLoS Negl Trop Dis 2010 1.61
24 A global comparative evaluation of commercial immunochromatographic rapid diagnostic tests for visceral leishmaniasis. Clin Infect Dis 2012 1.59
25 Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal--the challenges for diagnosis and treatment. Trop Med Int Health 2008 1.59
26 Trypanosomiasis control, Democratic Republic of Congo, 1993-2003. Emerg Infect Dis 2005 1.58
27 Present situation of vector-control management in Bangladesh: a wake up call. Health Policy 2008 1.54
28 How to shorten patient follow-up after treatment for Trypanosoma brucei gambiense sleeping sickness. J Infect Dis 2010 1.53
29 Long-lasting insecticidal nets fail at household level to reduce abundance of sandfly vector Phlebotomus argentipes in treated houses in Bihar (India). Trop Med Int Health 2008 1.51
30 Leishmaniases in the Mediterranean in the era of molecular epidemiology. Trends Parasitol 2008 1.50
31 Insecticide susceptibility of Phlebotomus argentipes in visceral leishmaniasis endemic districts in India and Nepal. PLoS Negl Trop Dis 2010 1.50
32 Response to treatment in a prospective cohort of patients with large ulcerated lesions suspected to be Buruli Ulcer (Mycobacterium ulcerans disease). PLoS Negl Trop Dis 2010 1.48
33 Visceral leishmaniasis in southeastern Nepal: a cross-sectional survey on Leishmania donovani infection and its risk factors. Trop Med Int Health 2006 1.43
34 Challenges in HIV and visceral Leishmania co-infection: future research directions. Trop Med Int Health 2010 1.41
35 Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome? Microbes Infect 2007 1.40
36 An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr 2009 1.40
37 Epidemiology of Leishmania donovani infection in high-transmission foci in Nepal. Trop Med Int Health 2010 1.36
38 The validity of serologic tests for Trypanosoma cruzi and the effectiveness of transfusional screening strategies in a hyperendemic region. Transfusion 2005 1.35
39 Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS Negl Trop Dis 2010 1.35
40 Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, India. Trop Med Int Health 2006 1.35
41 High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo. Emerg Infect Dis 2008 1.33
42 The epidemiology of Leishmania donovani infection in high transmission foci in India. Trop Med Int Health 2010 1.30
43 Measurement of recent exposure to Phlebotomus argentipes, the vector of Indian visceral Leishmaniasis, by using human antibody responses to sand fly saliva. Am J Trop Med Hyg 2010 1.30
44 Domestic animals and epidemiology of visceral leishmaniasis, Nepal. Emerg Infect Dis 2010 1.29
45 Interactions between Global Health Initiatives and country health systems: the case of a neglected tropical diseases control program in Mali. PLoS Negl Trop Dis 2010 1.26
46 Evaluation of leishmanin skin test in Indian visceral leishmaniasis. Am J Trop Med Hyg 2009 1.22
47 Diagnostic accuracy of a new Leishmania PCR for clinical visceral leishmaniasis in Nepal and its role in diagnosis of disease. Trop Med Int Health 2008 1.21
48 Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood. Clin Vaccine Immunol 2012 1.20
49 Barriers for introducing HIV testing among tuberculosis patients in Jogjakarta, Indonesia: a qualitative study. BMC Public Health 2008 1.20
50 Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol 2010 1.16
51 Double ethical review of North-South collaborative clinical research: hidden paternalism or real partnership? Trop Med Int Health 2011 1.16
52 Latent infection with Leishmania donovani in highly endemic villages in Bihar, India. PLoS Negl Trop Dis 2013 1.16
53 PCR and direct agglutination as Leishmania infection markers among healthy Nepalese subjects living in areas endemic for Kala-Azar. Trop Med Int Health 2009 1.16
54 Phlebotomus argentipes seasonal patterns in India and Nepal. J Med Entomol 2010 1.14
55 Voluntary counselling and testing uptake and HIV prevalence among tuberculosis patients in Jogjakarta, Indonesia. Trans R Soc Trop Med Hyg 2008 1.14
56 Human african trypanosomiasis diagnosis in first-line health services of endemic countries, a systematic review. PLoS Negl Trop Dis 2012 1.13
57 Population preference of net texture prior to bed net trial in Kala-Azar-endemic areas. PLoS Negl Trop Dis 2007 1.13
58 Interferon-gamma release assay (modified QuantiFERON) as a potential marker of infection for Leishmania donovani, a proof of concept study. PLoS Negl Trop Dis 2011 1.11
59 Persistent digestive disorders in the tropics: causative infectious pathogens and reference diagnostic tests. BMC Infect Dis 2013 1.11
60 Bayesian latent class models with conditionally dependent diagnostic tests: a case study. Stat Med 2008 1.10
61 Do patents prevent access to drugs for HIV in developing countries? JAMA 2002 1.09
62 Serological markers of sand fly exposure to evaluate insecticidal nets against visceral leishmaniasis in India and Nepal: a cluster-randomized trial. PLoS Negl Trop Dis 2011 1.08
63 Asymptomatic Leishmania infection: a new challenge for Leishmania control. Clin Infect Dis 2014 1.07
64 Vector control interventions for visceral leishmaniasis elimination initiative in South Asia, 2005-2010. Indian J Med Res 2012 1.07
65 Primary health care vs. emergency medical assistance: a conceptual framework. Health Policy Plan 2002 1.06
66 Visceral leishmaniasis in Muzaffarpur district, Bihar, India from 1990 to 2008. PLoS One 2011 1.06
67 Field validity, reproducibility and feasibility of diagnostic tests for visceral leishmaniasis in rural Nepal. Trop Med Int Health 2006 1.04
68 Human African trypanosomiasis in a rural community, Democratic Republic of Congo. Emerg Infect Dis 2007 1.04
69 Therapeutic itineraries of patients with ulcerated forms of Mycobacterium ulcerans (Buruli ulcer) disease in a rural health zone in the Democratic Republic of Congo. Trop Med Int Health 2009 1.04
70 [The efficiency of different detection strategies of human African trypanosomiasis by T. b. gambiense]. Trop Med Int Health 2005 1.03
71 Residual activity and integrity of PermaNet® 2.0 after 24 months of household use in a community randomised trial of long lasting insecticidal nets against visceral leishmaniasis in India and Nepal. Trans R Soc Trop Med Hyg 2011 1.03
72 Evaluation of latent class analysis and decision thresholds to guide the diagnosis of pediatric tuberculosis in a Rwandan reference hospital. Pediatr Infect Dis J 2010 1.02
73 Private practitioners and tuberculosis case detection in Jogjakarta, Indonesia: actual role and potential. Trop Med Int Health 2007 1.02
74 Serological markers for leishmania donovani infection in Nepal: Agreement between direct agglutination test and rK39 ELISA. Trop Med Int Health 2010 1.02
75 Comparative evaluation of freeze-dried and liquid antigens in the direct agglutination test for serodiagnosis of visceral leishmaniasis (ITMA-DAT/VL). Trop Med Int Health 2006 1.02
76 Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. Trans R Soc Trop Med Hyg 2007 1.01
77 Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Negl Trop Dis 2011 1.01
78 Engaging the private sector for tuberculosis control: much advocacy on a meagre evidence base. Trop Med Int Health 2007 1.00
79 Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr 2003 0.99
80 Should I get screened for sleeping sickness? A qualitative study in Kasai province, Democratic Republic of Congo. PLoS Negl Trop Dis 2012 0.99
81 Comparison of visceral leishmaniasis diagnostic antigens in African and Asian Leishmania donovani reveals extensive diversity and region-specific polymorphisms. PLoS Negl Trop Dis 2013 0.99
82 Novel markers for treatment outcome in late-stage Trypanosoma brucei gambiense trypanosomiasis. Clin Infect Dis 2008 0.98
83 Diagnostic accuracy of loopamp Trypanosoma brucei detection kit for diagnosis of human African trypanosomiasis in clinical samples. PLoS Negl Trop Dis 2013 0.98
84 Natural infection of Phlebotomus argentipes with Leishmania and other trypanosomatids in a visceral leishmaniasis endemic region of Nepal. Trans R Soc Trop Med Hyg 2009 0.97
85 Molecular and serological markers of Leishmania donovani infection in healthy individuals from endemic areas of Bihar, India. Trop Med Int Health 2013 0.97
86 Visceral leishmaniasis and arsenic: an ancient poison contributing to antimonial treatment failure in the Indian subcontinent? PLoS Negl Trop Dis 2011 0.96
87 Visceral leishmaniasis in rural bihar, India. Emerg Infect Dis 2012 0.96
88 Failure of miltefosine in visceral leishmaniasis is associated with low drug exposure. J Infect Dis 2014 0.96
89 Infection rates with Leishmania donovani and Mycobacterium tuberculosis in a village in eastern Sudan. Trop Med Int Health 2004 0.95
90 A new PCR-ELISA for diagnosis of visceral leishmaniasis in blood of HIV-negative subjects. Trans R Soc Trop Med Hyg 2005 0.95
91 Effect of a control project on clinical profiles and outcomes in buruli ulcer: a before/after study in Bas-Congo, Democratic Republic of Congo. PLoS Negl Trop Dis 2011 0.95
92 Research priorities for neglected infectious diseases in Latin America and the Caribbean region. PLoS Negl Trop Dis 2010 0.94
93 Incidence of surgical-site infections and the validity of the National Nosocomial Infections Surveillance System risk index in a general surgical ward in Santa Cruz, Bolivia. Infect Control Hosp Epidemiol 2003 0.93
94 Cost-effectiveness of algorithms for confirmation test of human African trypanosomiasis. Emerg Infect Dis 2007 0.93
95 The household costs of visceral leishmaniasis care in south-eastern Nepal. PLoS Negl Trop Dis 2013 0.92
96 Effect of untreated bed nets on blood-fed Phlebotomus argentipes in kala-azar endemic foci in Nepal and India. Mem Inst Oswaldo Cruz 2009 0.92
97 Cost-effectiveness of a community-based approach intertwined with a vertical Aedes control program. Am J Trop Med Hyg 2009 0.91
98 Human African trypanosomiasis in the Democratic Republic of the Congo: a looming emergency? PLoS Negl Trop Dis 2012 0.91
99 Commentary: Substandard medicines are the priority for neglected tropical diseases. BMJ 2012 0.90
100 Epidemiology and clinical features of patients with visceral leishmaniasis treated by an MSF clinic in Bakool region, Somalia, 2004-2006. PLoS Negl Trop Dis 2007 0.90
101 Editorial: The AIDS crisis, cost-effectiveness and academic activism. Trop Med Int Health 2002 0.89
102 Combination therapy for visceral leishmaniasis. Lancet 2011 0.89
103 Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India. Trop Med Int Health 2012 0.89
104 HIV-1 protease inhibitors for treatment of visceral leishmaniasis in HIV-co-infected individuals. Lancet Infect Dis 2013 0.89
105 The incremental cost-effectiveness of engaging private practitioners to refer tuberculosis suspects to DOTS services in Jogjakarta, Indonesia. Am J Trop Med Hyg 2010 0.89
106 The economic burden of visceral leishmaniasis in Sudan: an assessment of provider and household costs. Am J Trop Med Hyg 2013 0.89
107 Lay perceptions of kala-azar, mosquitoes and bed nets in Bihar, India. Trop Med Int Health 2010 0.88
108 Costs of dengue prevention and incremental cost of dengue outbreak control in Guantanamo, Cuba. Trop Med Int Health 2011 0.88
109 Burden of Mycobacterium ulcerans disease (Buruli ulcer) and the underreporting ratio in the territory of Songololo, Democratic Republic of Congo. PLoS Negl Trop Dis 2013 0.88
110 Development of an enzyme-linked immunosorbent assay to identify host-feeding preferences of Phlebotomus species (Diptera: Psychodidae) in endemic foci of visceral leishmaniasis in Nepal. J Med Entomol 2010 0.88
111 Diagnostic accuracy and feasibility of serological tests on filter paper samples for outbreak detection of T.b. gambiense human African trypanosomiasis. Am J Trop Med Hyg 2010 0.87
112 Challenge of reducing perinatal mortality in rural Congo: findings of a prospective, population-based study. J Health Popul Nutr 2011 0.87
113 Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials. Infect Immun 2009 0.86
114 Spatial analysis of Leishmania donovani exposure in humans and domestic animals in a recent kala azar focus in Nepal. Parasitology 2010 0.86
115 Clinical aspects of paediatric visceral leishmaniasis in North-west Ethiopia. Trop Med Int Health 2014 0.86
116 Intersectoral collaboration between the medical and veterinary professions in low-resource societies: The role of research and training institutions. Comp Immunol Microbiol Infect Dis 2012 0.85
117 Mycobacterium ulcerans infection (Buruli ulcer) on the face: a comparative analysis of 13 clinically suspected cases from the Democratic Republic of Congo. Am J Trop Med Hyg 2011 0.85
118 An outbreak investigation of visceral leishmaniasis among residents of Dharan town, eastern Nepal, evidence for urban transmission of Leishmania donovani. BMC Infect Dis 2013 0.85
119 Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project. Trop Med Int Health 2013 0.85
120 Poor-quality medical products: time to address substandards, not only counterfeits. Trop Med Int Health 2012 0.85
121 Vitamin D deficiency and hyperparathyroidism in relation to ethnicity: a cross-sectional survey in healthy adults. Eur J Nutr 2008 0.85
122 Adherence to miltefosine treatment for visceral leishmaniasis under routine conditions in Nepal. Trop Med Int Health 2012 0.84
123 Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent. J Infect Dis 2012 0.84
124 Therapeutic feeding centres for severe malnutrition. Lancet 2002 0.84
125 A CATT negative result after treatment for human African trypanosomiasis is no indication for cure. PLoS Negl Trop Dis 2010 0.83
126 Treatment failure related to intrathecal immunoglobulin M (IgM) synthesis, cerebrospinal fluid IgM, and interleukin-10 in patients with hemolymphatic-stage sleeping sickness. Clin Vaccine Immunol 2007 0.82
127 Comparative evaluation of blood and serum samples in rapid immunochromatographic tests for visceral leishmaniasis. J Clin Microbiol 2013 0.81
128 NTD control and health system strengthening. Lancet 2012 0.81
129 [Community participation in Dengue prevention: an approach from the perspective of different social actors]. Salud Publica Mex 2006 0.81
130 Household cost-of-illness of visceral leishmaniasis in Bihar, India. Trop Med Int Health 2010 0.80
131 Burden of visceral leishmaniasis in villages of eastern Gedaref State, Sudan: an exhaustive cross-sectional survey. PLoS Negl Trop Dis 2012 0.80
132 Strong general health care systems: a prerequisite to reach global tuberculosis control targets. Int J Health Plann Manage 2003 0.80
133 Post-kala-azar dermal leishmaniasis (PKDL) in visceral leishmaniasis-endemic communities in Bihar, India. Trop Med Int Health 2012 0.79
134 Deltamethrin and permethrin residue on long-lasting insecticidal nets after 18 months of use in a visceral leishmaniasis-endemic area in Nepal. Trans R Soc Trop Med Hyg 2012 0.79
135 The ethics of non-inferiority trials. Lancet 2008 0.78
136 Effect of applying a treatment threshold in a population. An example of pulmonary tuberculosis in Rwanda. J Eval Clin Pract 2010 0.76
137 Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerable. Expert Rev Anti Infect Ther 2012 0.76
138 Reply to Arya and Agarwal. Clin Infect Dis 2013 0.75
139 Leishmaniasis direct agglutination test: using pictorials as training materials to reduce inter-reader variability and improve accuracy. PLoS Negl Trop Dis 2012 0.75
140 The need for strong general health services in India and elsewhere. Lancet 2007 0.75
141 How do health care providers deal with kala-azar in the Indian subcontinent? Indian J Med Res 2011 0.75
142 Iodine nutritional status in Tibet. Lancet 2008 0.75
143 Antioxidant supplements for prevention of gastrointestinal cancers. Lancet 2005 0.75
144 Low back pain in rural Tibet. Lancet 2003 0.75
145 Reply to Das. Clin Infect Dis 2013 0.75
146 [Community participation in the control of Aedes aegypti: opinions of the population in one section of Havana, Cuba]. Rev Panam Salud Publica 2004 0.75
147 [The origin of Ebola: Biomedical approach versus popular interpretations in Macenta, Guinea]. Sante Publique 2017 0.75
148 Iodine deficiency mitigates growth retardation and osteopenia in selenium-deficient rats. J Nutr 2006 0.75
149 Universal access to quality medicines: prioritisation of a-priori solutions. Lancet Infect Dis 2012 0.75